Francisca M. M.
- Country
- Spain
- Department
- N/A
Research Overview
- Evaluation of Atezolizumab Combined with Radiotherapy in Muscle-Invasive Bladder Cancer Patients for Pathological Complete Response
- Phase 3 Randomized, Double-Blind Trial of Talazoparib and Enzalutamide Versus Placebo and Enzalutamide in DDR Gene Mutated Metastatic Castration-Sensitive Prostate Cancer
Data & Insights
Has run more than one trial at 3 of 68 partner sites.
Specializations
Oncology Focus
This investigator specializes in studying metastatic castration-sensitive prostate cancer, with particular emphasis on advanced therapeutic approaches for patients with specific genetic mutations.
- Prostate Cancer Treatment
- Metastatic Disease Management
- Targeted Therapy Applications
The research centers on evaluating novel therapeutic combinations for improving patient outcomes in advanced prostate cancer cases.
Genetic Medicine
The investigator's work encompasses the study of DNA damage repair (DDR) gene mutations and their role in cancer treatment response, particularly in prostate cancer therapy.
- Genetic Mutation Analysis
- Biomarker Research
- Personalized Treatment Approaches
Their research explores how genetic factors influence treatment efficacy in advanced cancer cases.
Treatment Innovation
The investigator focuses on evaluating combination therapy approaches in oncology, specifically investigating novel drug combinations for treating advanced prostate cancer.
- Therapeutic Combinations
- Disease Progression Assessment
- Clinical Outcomes Research
Their work involves assessing radiographic progression-free survival in advanced cancer treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.